Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $226.77 +0.94%
EPS Growth %: +174.9%
Financial Fact:
Total revenues: 374.18M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +174.9%
Financial Fact:
Total revenues: 374.18M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) reported Q4 EPS of $1.17, $0.08 better than the analyst estimate of $1.09. Revenue for the quarter came in at $83.5 million versus the consensus estimate of $80.84 million.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Playboy to buy back 16.6M shares from Fortress at $1.05 each
- Worried the AI trade has gone too far? Evercore likes these 4 stocks
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
